Clinical and radiographic characterization of xenotransplantation of rat bonemarrow-derived mesenchymal stem cells for repair of radial defects of rabbit

Abstract

IntroductionMesenchymal stem cells (MSCs) are defined as a population of multipotent cells able to differentiate and produce any cell type needed in a repair process, such as osteoblasts, chondroblasts, neurons, epithelial cells, and cardiac cells (1,2).This cell type has become the focus of numerous studies worldwide for providing clinically promising perspectives for cell therapy and also for its immunomodulatory potential (3,4), although the mechanisms of immunosuppression on inflammatory response and the mechanisms of transplant rejection are not fully elucidated (5).Recent studies have described the use of allogeneic and autologous MSCs for the repair of various tissues (4,6). However, there is little research involving xenotransplantation in animals and most of them only evaluated the cellular interaction in vitro between MSCs and T lymphocytes.Because of the great therapeutic potential of MSCs, in addition to the persistent doubts about their immunosuppressive capacity in vivo, further studies are needed to investigate the real potential of xenogenic transplantation using these cells for tissue repair in animals. Therefore, this study evaluated clinical and radiographic aspects of xenogenic transplantation of rat bone marrow-derived MSCs for the repair of radial bone defects created in rabbits. Materials and methodsThis study was approved by the Institutional Animal Care Committee (protocol 97/2010). Cellular cultureA total of five male, 4-week old Wistar rats were euthanized using anesthetic overdose. The animals were immersed in alcohol 70° to ensure antisepsis for cell collection and were taken to the laminar flow cabinet. The femurs were disarticulated and removed aseptically. The distal epiphyses were cut and the medullary canal was flushed with Dulbecco's modified Eagle's medium (DMEM, Gibco, Grand Island, NY, USA) with low glucose, containing 10% fetal bovine serum (FBS) (Gibco), 50.0 mg L -1 gentamicin,

Research Article Mesenchymal stem cell infusion for the treatment of neurological sequelae of canine distemper virus: a clinical study

“…All the animals underwent three allogenic MSC infusions, at a dose of 5.0 x 10 6 cells/3.0 mL of PBS (phosphate buffered saline), intravenously, on days 1, 15, and 30 of the study. The MSCs used during the study were processed in the UVV Stem Cell and Animal Therapy Laboratory(LCET) in accordance with pre-established protocols for the laboratory routine (Monteiro et al, 2015;Oliveira et al, 2017). After each treatment, the owners were instructed to contact the researchers if they observed any behavioral or clinical changes in the patients.…”

Adipose tissue derived mesenchymal stem cell transplantation in the treatment of ischemia/reperfusion induced acute kidney injury in rats. Application route and therapeutic window

“…Two-dimensional and color Doppler ultrasound examinations were performed in 16 randomly selected animals at 7 days before the surgical procedure to determine patterns of normality of the structural organ and hemodynamics using an ultrasound equipment (GE Logiq-E) with sector transducer 8C (4)(5)(6)(7)(8)(9)(10)(11). In these animals, color Doppler ultrasound was also performed after the placement and removal of the vascular clip, allowing the assessment of renal ischemia and reperfusion.…”